Table 4. Attempt to replicate the results of the pathway analysis in the second phase of data from the GenoMEL GWA study.
Set | SUMSTAT | SUMSQ |
All genes | 0.167 | 0.280 |
Anergy | 0.001 | 0.002 |
Costim. | 0.291 | 0.411 |
Treg | 0.690 | 0.794 |
Secreted | 0.738 | 0.783 |
tDC | 0.701 | 0.761 |
1450 melanoma cases and 4047 controls were included in the analysis. Empirical p-values established by 1000 in-cluster (GenoMEL regional groups: Israel, Italy, France, Poland, Scandinavia, Spain, UK/Netherlands) label permutations are shown for the pathway statistics SUMSTAT and SUMSQ.